We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Polarean Imaging Plc | LSE:POLX | London | Ordinary Share | GB00BF3DT583 | ORD GBP0.00037 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -1.33% | 3.70 | 3.60 | 3.80 | 3.75 | 3.70 | 3.75 | 207,491 | 15:14:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 1.03M | -13.91M | -0.0644 | -0.57 | 7.99M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/12/2023 16:38 | Virtually no trading after 12.30pm. So what’s brought the share price back down? | wetdream | |
08/12/2023 13:22 | Thank you Nigelpm. Appreciated. I mean no ill, it is just my view. | purchaseatthetop | |
08/12/2023 13:11 | Hopefully get some more coverage over the weekend . 10p plus next week | moontheloon | |
08/12/2023 12:17 | I wouldn't call PATT a clown - he's been consistently right to date. Yesterday was a fundamental shift however and the idea of it not being commercial has been banished into the wilderness with an order outside of the research environment. | nigelpm | |
08/12/2023 12:10 | Z1CO spot on one clown was banging on about. The Polarean TECH isnt needed" and a 3p placing. I think you can probably guess which clown of the 3 clowns that was. | john henry | |
08/12/2023 12:01 | ZICO. No. It was simply saying they have to raise cash before the end of Feb 24 because they would never let the cash runway drop below 6 months. That is just my view. The whole point of the cash runway is that they need cash before it runs out and they don’t wait for £1 left. | purchaseatthetop | |
08/12/2023 11:58 | The shares opened at 5.5p and the derampers were trying to scare potential buyers. Absolutely pathetic lot to say the least. A few example: pre7 Dec '23 - 09:24 - 5898 of 5992 0 0 0 Will get them cheaper by close- sellers will appear shortly as many pi’s don’t hold for a day let alone a few hours! ==================== bones6987 Dec '23 - 07:33 - 5863 of 5992 0 0 2 Well up a fraction at open but won't last long as reality sets in and cash is needed very soon . Plus lack of revenue and little substance just more jam in a few years at earliest ==================== purchaseatthetop7 Dec '23 - 07:11 - 5857 of 5992 0 3 2 “The Company's current cash runway is expected to last into Q3-2024. Management is continuing to evaluate all options for further financing and will update the market further when appropriate to do so.” Matter of a couple of months before raise. ==================== POSTERS LIKE THESE SHOULD BE AVOIDED. | z1co | |
08/12/2023 10:31 | @Seball, check CvJ’s LinkedIn following Polx attendance at the RNSA meeting last week. He stated how successful the conference had been which was endorsed by Bill Blair (Amati’s Man) with the following comment “Sounds a great meeting and opportunity to discuss the benefits of Polarean's Ground-Breaking Technology”. This was subsequently liked by CvJ This doesn’t sound like a comment a Amati would public make if they were selling out!! IMO - quite the opposite hxxps://www.linkedin | dym turbo | |
08/12/2023 10:30 | Imho we will see the start of clinical roll outs 1st quarter next year and the beginning of exponential growth | john henry | |
08/12/2023 10:30 | The daily percentage gains look great, however the capital gain in MKT Cap is tiny. | john henry | |
08/12/2023 10:28 | I think chances are we say a DD rns in next day or two . | moontheloon | |
08/12/2023 10:27 | Agreed Tutte. Risk:reward with yesterday's RNS has shifted hugely to the reward side. | nigelpm | |
08/12/2023 10:24 | Nice to have the wise tutte words on the thread ;) | moontheloon | |
08/12/2023 10:21 | Drop here is overdone and Polarean is extremely undervalued. I have topped up today as more funds have became available. Good luck all | seball | |
08/12/2023 10:19 | Another excellent volume day. | john henry | |
08/12/2023 10:11 | I am pretty comformtable to Zig when Justin Waite Zags .... I still recall his 100X video for POLX. He is especially clueless when it comes to pharma development and healthcare. Clinically and commercially POLX has done a decent job given it is a small independent outfit with De Novo capital sales technology and is bang in the middle of the bell curve for outcomes. Any expectation it should be significantly ahead at this point was always unrealistic unless it had access to the money and leverage of a large OEM. Enormous and nieve expectations were built up in this name and now we have now gone to the other extreme. With the CPT codes and rates obtained and the first DeNovo sale behind us commercial risk has fallen dramatically. As for cash it will only come from a CR if they have no other alternative and my bet is they do, but happy to participate in equity raise if they don't. | w t tutte | |
08/12/2023 10:08 | It's not "obvious" - it's still a tough gig here. | nigelpm | |
08/12/2023 10:07 | Looks like bargain hunters hoovering up shares. Any more news on sales and this will rerate. Strong Buy imo | seball | |
08/12/2023 10:00 | So obvious when you've bought and sold Nigel. | moontheloon | |
08/12/2023 09:58 | A 2 year run would reassure re funding as Paul stated somewhere. More uptake would help. Come on POLX! | raleigh43 | |
08/12/2023 09:55 | I thought VOX's analysis was spot on. They are still in a difficult position RE: funding. | nigelpm | |
08/12/2023 09:20 | DYM Turbo - Have you a link? Thanks | seball | |
08/12/2023 09:17 | I noticed VOX had a slightly negative slant, sore grapes comes to mind. Focusing very much on the funding and not on the progression of the Business. | john henry | |
08/12/2023 09:14 | DYM Turbo i didnt realise Amati had an appointed man on Social Media LOL | john henry |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions